Project Grant R43HL169137
Award Date
8/15/23
Completion Date
7/31/24
Dollars Obligated
$276K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This $117,750 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund a study investigating the prospective associations between neighborhood environment features and physical activity, as well as weight status, across different age groups. The study will leverage data from five existing NIH-funded studies to efficiently examine long-term impacts over 5-15 year periods. Key objectives include...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $691,326 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Northwestern University to develop a "4D Right-Heart Virtual Catheter (4D VCATH)". This novel technology combines advanced mathematical modeling and 4D flow MRI to provide a comprehensive, non-invasive hemodynamic analysis of the right heart chambers. The project aims to enable streamlined diagnosis, classification, and prognosis...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to develop a Pediatric Airway Shape Atlas (PASA) that provides comprehensive 3D modeling and quantification of upper airway geometry in children. The $329,610 award to the University of California, San Diego will create computational methods to analyze static and dynamic CT images, allowing for improved, non-invasive assessment of...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $477,191 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Phrase Health, Inc., a small disadvantaged business located in Philadelphia, PA. The purpose of this 22-month project is to develop a library of "out of the box" quality improvement (QI) templates focused on select lung diseases, including asthma, bronchiolitis, and COPD. The project will involve translating existing QI project templates from...
The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $1,208,196 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Pip Care, Inc. The award supports the development and evaluation of a personalized, interactive digital health platform with a virtual health coach to optimize perioperative care and improve outcomes for surgical patients. Key objectives include expanding the platform's clinical...
This $540,771 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a personalized, socially-conscious stroke risk stratification tool for patients with atrial fibrillation (AF). The key products and services to be delivered include: Discovery of new clinical and socioeconomic risk factors for stroke in AF patients by leveraging large datasets that include social determinants of health...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $162,000 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Connecticut. The grant will fund a 12-week proof-of-concept study testing a technology-delivered mindful walking intervention to reduce stress, increase physical activity, and lower blood pressure in Black women with hypertension. The project aims to address disparities in hypertension and physical activity rates among...
This $347,527.92 Project Grant from the National Heart, Lung and Blood Institute of the Department of Health and Human Services will fund the development of a clinical decision support tool to maximize outcomes for obesity treatment in primary care. The grant recipient, Dr. Hallie Espe-Huynh of The Miriam Hospital, will work with stakeholders to design a machine learning model within a prototype clinical decision support system. The tool aims to predict early risk of nonresponse to online...
This Project Grant award for $691,708.00 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program supports the development of a novel contrast-free ultrasound-based quantitative angio flow imaging technique to assess peripheral arterial disease (PAD) of the lower limbs. The research project aims to determine the efficacy of this new "Angio Flow Reactivity Analysis" (AFRA) method for assessing PAD in patient...
This $686,458 Project Grant was awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The grant supports a collaborative research effort between multiple institutions, led by Yale University, to develop a quantitative, predictive model of vascular remodeling in health and disease. The key products and services to be delivered through this grant include: Characterizing the roles of vascular endothelial...